Measuring Mast Cell Exocytosis via Neuropeptide Y Monomeric Red Fluorescent Protein Release
JoVE Encyclopedia of Experiments
Immunology
0 views • 3:14 min • July 8th, 2025
Loading...
Overview
This article demonstrates a quantitative method to investigate mast cell exocytosis by tracking the release of secretory granules containing the fluorescent reporter protein NPY-mRFP. The protocol utilizes a calcium ionophore to induce exocytosis and employs fluorescence measurements to assess the extent of granule release.
Key Study Components
Area of Science
- Cell Biology
- Immunology
- Fluorescence Assays
Background
- Mast cells play a crucial role in immune responses by releasing mediators stored in secretory granules.
- Exocytosis is triggered by increased intracellular calcium levels.
- Fluorescent reporter proteins enable visualization and quantification of granule release.
- Understanding mast cell degranulation is important for allergy and inflammation research.
Purpose of Study
- To visualize and quantify mast cell exocytosis using a fluorescent reporter.
- To establish a reproducible protocol for measuring secretory granule release.
- To assess the efficiency of exocytosis upon stimulation with a calcium ionophore.
Methods Used
- Transfection of mast cells with NPY-mRFP to label secretory granules.
- Stimulation of cells with a calcium ionophore in calcium-containing buffer.
- Collection of supernatant and cell lysate after incubation.
- Quantitative fluorescence measurement using a plate reader (excitation at 590 nm, emission at 635 nm).
Main Results
- Calcium ionophore treatment induces exocytosis and release of NPY-mRFP from mast cells.
- Fluorescence measurements of supernatant and lysate allow calculation of the percentage of released granules.
- The protocol enables sensitive and quantitative assessment of mast cell degranulation.
- Control (unstimulated) and stimulated samples can be directly compared.
Conclusions
- This method provides a robust approach for quantifying mast cell exocytosis.
- Fluorescent reporters like NPY-mRFP facilitate sensitive detection of granule release.
- The assay can be adapted for studies of mast cell function and regulation.
Frequently Asked Questions
What is the purpose of using NPY-mRFP in this assay?
NPY-mRFP is a fluorescent fusion protein that labels secretory granules, enabling visualization and quantification of their release during mast cell exocytosis.
How is exocytosis induced in the mast cells?
Exocytosis is triggered by adding a calcium ionophore in a calcium-containing buffer, which increases intracellular calcium and mobilizes granules to the plasma membrane.
How is the amount of released NPY-mRFP measured?
The released NPY-mRFP in the supernatant and the remaining intracellular NPY-mRFP in the lysate are quantified using a fluorescence plate reader.
Why is Triton X-100 used in the protocol?
Triton X-100 is a non-ionic detergent used to lyse the cells, releasing any NPY-mRFP that was not secreted, allowing for total fluorescence measurement.
What controls are included in the experiment?
Unstimulated cells treated with buffer alone serve as controls to compare against the stimulated, ionophore-treated cells.
What are the excitation and emission settings for fluorescence measurement?
Fluorescence is measured with a 590 nm excitation filter (20 nm bandwidth) and a 635 nm emission filter (35 nm bandwidth).
Can this method be adapted for other secretory cell types?
Yes, the approach can be adapted to study exocytosis in other cell types by expressing appropriate fluorescent granule markers.
Executive Industry Relevance
Quantitative measurement of mast cell exocytosis using NPY-mRFP release provides a robust platform for interrogating secretory pathway mechanisms in immune cell biology. This fluorescence-based assay enables high-confidence assessment of granule release dynamics, supporting predictive evaluation of target engagement and pathway modulation in early discovery. The approach is directly relevant for de-risking immunological targets and optimizing assay systems for translational research portfolios.
Strategic Applications in Biopharma R&D
Early Discovery & Target Validation
- Enables quantitative interrogation of mast cell degranulation mechanisms for target validation.
- Supports functional assessment of candidate modulators impacting exocytosis pathways.
- Facilitates mechanistic de-risking by providing direct readouts of secretory activity.
- Improves predictive confidence in immune cell pathway modulation strategies.
Screening & Assay Development
- Establishes a reproducible, fluorescence-based assay for high-throughput screening of modulators.
- Delivers standardized, quantitative outputs for reliable compound evaluation.
- Supports assay scalability and platform reuse across immune cell models.
- Enables direct comparison of stimulated versus control conditions for robust assay validation.
Translational & Preclinical Research
- Aligns with disease-relevant immune cell function studies for translational biomarker development.
- Provides continuity from discovery-stage mechanistic studies to preclinical validation of immune modulators.
- Supports risk-adjusted advancement decisions by quantifying functional cellular responses.
Pipeline & Workflow Integration
This fluorescence-based exocytosis assay integrates into the discovery-to-preclinical continuum, supporting both early mechanistic studies and downstream screening workflows.
- Discovery Biology: Quantifies secretory granule release to clarify immune cell pathway function and validate targets.
- Screening: Provides standardized, reproducible outputs for compound screening and assay optimization.
- Analytics: Enables quantitative comparison of exocytosis across experimental conditions using fluorescence readouts.
- Translational Research: Bridges mechanistic discovery with preclinical immune function studies when aligned with disease models.
- Enterprise Reuse: Offers a reusable assay platform adaptable to various secretory cell types and immune targets.
Operational & Enterprise Impact
- Scientific Value: Increases predictive confidence and reduces mechanistic ambiguity in immune cell target validation.
- Operational Value: Delivers standardized, scalable, and reproducible assay workflows for cross-team adoption.
- Strategic Value: Supports informed go/no-go decisions and capital-efficient portfolio advancement.
- Portfolio Impact: Enables risk-adjusted prioritization of immune modulation programs based on quantitative functional data.
Implementation Considerations
- Requires expertise in fluorescence assay design and immune cell handling.
- Needs access to fluorescence plate readers with appropriate excitation/emission settings.
- Demands cross-team standardization of assay protocols and data analysis.
- Adaptable to other secretory cell models with suitable fluorescent reporters.
- Dependent on robust transfection and cell viability for reproducible outputs.
Biopharma FAQs
Why does null hypothesis testing matter for NPY-mRFP exocytosis quantification?
Null hypothesis testing enables objective comparison between stimulated and control mast cell samples, ensuring that observed NPY-mRFP release reflects true exocytosis rather than background variability. This statistical rigor is essential for target validation and mechanistic de-risking in discovery workflows.
How does independent variable isolation fit the calcium ionophore stimulation workflow?
Isolating the calcium ionophore as the activating reagent allows precise attribution of exocytosis effects to calcium influx, supporting clear mechanistic interpretation and reducing confounding variables in early discovery studies.
What do quantitative fluorescence measurements of NPY-mRFP enable in screening?
Quantitative fluorescence measurements provide standardized, reproducible outputs that facilitate direct comparison of compound effects on mast cell exocytosis, enabling reliable screening and assay optimization for immune modulators.
Why are replication requirements critical for cross-functional mast cell assays?
Replication ensures that NPY-mRFP release measurements are robust and reproducible across teams, supporting cross-functional collaboration and confidence in assay results for portfolio decision-making.
What statistical analysis capabilities are required before implementing NPY-mRFP release assays?
Implementation requires statistical tools to compare fluorescence outputs between control and stimulated samples, assess assay variability, and validate significance thresholds, ensuring data integrity for R&D advancement.
04:50
Imaging FITC-dextran as a Reporter for Regulated Exocytosis
Related Videos
0 Views
10:21
Quantifying Spatiotemporal Parameters of Cellular Exocytosis in Micropatterned Cells
Related Videos
0 Views
13:28
Automated Detection and Analysis of Exocytosis
Related Videos
0 Views
06:56
Measuring Exocytosis in Neurons Using FM Labeling
Related Videos
0 Views
04:08
Mast Cell Degranulation Assay to Study the Effect of a Target Chemical
Related Videos
0 Views
03:34
An In Vitro Technique to Visualize Exocytosis of Secretory Granules in Mast Cells
Related Videos
0 Views
13:47
TIRFM and pH-sensitive GFP-probes to Evaluate Neurotransmitter Vesicle Dynamics in SH-SY5Y Neuroblastoma Cells: Cell Imaging and Data Analysis
Related Videos
0 Views
16:01
Investigating Mast Cell Secretory Granules; from Biosynthesis to Exocytosis
Related Videos
0 Views
07:30
Measuring Synaptic Vesicle Endocytosis in Cultured Hippocampal Neurons
Related Videos
0 Views
09:41
Confocal Imaging of Neuropeptide Y-pHluorin: A Technique to Visualize Insulin Granule Exocytosis in Intact Murine and Human Islets
Related Videos
0 Views
Last updated: 1 August 2026